Stephen Knight
President & Senior Managing Partner·F-Prime
Stephen Knight is President and Senior Managing Partner at F-Prime Capital, based in Cambridge. He joined the firm in 2003 and invests broadly across healthcare after more than 30 years in the pharmaceutical and biotechnology industries. His official profile lists board roles at Atalanta Therapeutics, Leyden Labs, Paradigm, Quarry Thera, and Xaira Therapeutics, as well as past involvement with many public and acquired healthcare companies. Before F-Prime, he held senior management roles in biotechnology and consulting and conducted research at AT&T Bell Laboratories, the National Institutes of Health, and Yale University. He holds an MD and MBA from Yale and a BS in biology from Columbia University.
See the rest of Stephen Knight's profile.
Deal history, investment focus, outreach angles and the rest of the background. One email, no password — we send a link and you land right back here.